Drug Retail

Some of the stocks that may grab investor focus today are: Wall Street expects General Motors Company (NYSE: GM) to report its Q2 EPS at $1.20 on revenue of $36.71 billion. GM shares surged 1.21% to $27.50 in after-hours trading. Zumiez Inc (NASDAQ: ZUMZ) reported a 4.9% rise in its July sales at...

Walgreens (NYSE: WAG) (NASDAQ: WAG) had July sales of $5.82 billion, an increase of 4.7 percent from $5.56 billion for the same month in 2010. Total front-end sales increased 6.8 percent in July, while comparable store front-end sales increased 4.8 percent. Customer traffic in comparable stores...

CVS Caremark (NYSE: CVS) unveils its next round of earnings this Thursday, August 4, 2011. Get prepared with Benzinga's ultimate preview for CVS Caremark's second quarter earnings. Earnings and Revenue: Analysts are predicting an EPS reading of 64 cents/share and revenues of $26.76 billion....

Cardinal Health (NYSE: CAH) announces its next round of earnings this Thursday, August 4, 2011. Get the latest predictions in Benzinga's essential guide to the company's fourth quarter earnings report. Earnings and Revenue: Ahead of the company's earnings announcement, analysts are expecting...

JP Morgan has published a research report on CVS Caremark Corporation (NYSE: CVS) and has added the company to JP Morgan's Analyst Focus List with a raised price target of $50, up from $43. In the report, JP Morgan writes, "We point to 4 reasons: 1) a return to double-digit PBM EBIT growth in...

JP Morgan has raised the price target on CVS Caremark Corporation (NYSE: CVS) from $43 to $50 and maintains its Overweight rating.

Quarterly reports of note scheduled for this week include those from Archer Daniels Midland (NYSE: ADM), General Motors (NYSE: GM), MasterCard (NYSE: MA), Procter & Gamble (NYSE: PG) and Time Warner (NYSE: TWX), all of which are expected to post earnings growth, as well as Pfizer (NYSE: PFE)...

Rite Aid Corporation (NYSE: RAD) today announced sales results for July. For the four weeks ended July 23, 2011, same store sales increased 1.9 percent over the prior-year period. July front-end same store sales increased 3.1 percent while pharmacy same store sales, which included an approximate...

On CNBC's Fast Money, Dan Nathan said that investors should be defensive and buy weekly puts in SPDR S&P 500 ETF (NYSE: SPY) on Wednesday. SPDR S&P 500 ETF (SPY) fell 0.37% today, and it closed at $133.33. Guy Adami likes Church & Dwight Co., Inc. (NYSE: CHD), and wants to buy it...

Access Community Health Network CEO Donna Thompson today announced new initiatives with Walgreens (NYSE: WAG) that will help ACCESS fulfill its mission to provide high-quality, accessible health care to residents in underserved communities. Create a pharmacy and therapeutics committee that will...

Overall, retail sales have sputtered in recent reports. But not all is doom and gloom in the sector; here are seven retail stocks that are on a tear. All of them hit 52-week highs yesterday, and all are up more than 20% since the beginning of the year (or in one case, since its IPO earlier this...

In conjunction with efforts by First Lady Michelle Obama and the Partnership for a Healthier America to fight the childhood obesity epidemic and provide better food options and accessible health care to under-served communities, Walgreens (NYSE: WAG) (NASDAQ: WAG) today announced at the White House...

Medco Health Solutions (NYSE: MHS) earnings are right around the corner! Don't be caught off-guard: The company unveils its next round of earnings this Thursday, July 21, 2011. Want to get all the facts ahead of this Thursday's announcement? We thought so. Here's an advanced look at Medco Health...

Pacific Booker Minerals Inc (AMEX: PBM) shares gained 30.57% to $10.25 at 9:50 am. PBM had no debt for the latest quarter. Bacterin International Holdings Inc (AMEX: BONE) climbed 26.29% to $2.93. BONE acquired the assets of Robinson MedSurg LLC. Pharmaceutical Product Development Inc (NASDAQ:...

Scotia Capital is out with a research report on Walgreen Company (NYSE: WAG) after the company raised its dividend and announced a new buyback. It has a one year price target of $46 and a Sector Outperform rating. In a note to clients, Scotia Capital writes, "Investors will certainly welcome WAG'...